Anonymous wrote:Anonymous wrote:Anonymous wrote:Isn't the mortality rate believed to be around 1%? That's pretty high!
The most recent study saw a mortality for this clade of a little over 3%. However, it is higher in children and immunocompromised persons.
NYT Spelling Bee enthusiasts, take note.
Anonymous wrote:That study analyzes cases 30-50 years old. This is a different strain, and medicine has advanced a bit.
The person who died in Brazil had cancer and was HIV+. Undoubtedly, there will some other hook factor like this with the two young Spaniards who died.
Anonymous wrote:Anonymous wrote:Anonymous wrote:Isn't the mortality rate believed to be around 1%? That's pretty high!
The most recent study saw a mortality for this clade of a little over 3%. However, it is higher in children and immunocompromised persons.
NYT Spelling Bee enthusiasts, take note.
Anonymous wrote:There is no accurate way to know the mortality rate since it hasn't been around widely in countries with good health care. This is probably as dangerous as chicken pox -- people with no access to health care and antibiotics pick at the scabs, they get infected and are left untreated. Nothing to be concerned about here, where we have access to health care and antibiotics.
Anonymous wrote:Anonymous wrote:Anonymous wrote:Anonymous wrote:Isn't the mortality rate believed to be around 1%? That's pretty high!
The most recent study saw a mortality for this clade of a little over 3%. However, it is higher in children and immunocompromised persons.
Citation?
3.6%
https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0010141
Our analysis shows that in the early years (1970–1989), monkeypox was primarily a disease of young children, with a median age at presentation of 4 to 5 years old; this increased to 10 years of age in 2000–2009 and 21 years in 2010–2019. Regarding age at death in monkeypox cases, 100% of deaths were in children <10 years of age in the early years, while for the years 2000–2019, age <10 years accounted for only 37.5% of deaths. These data appear to be consistent with the global intensified smallpox eradication program that began in 1967 [86] and the cease of routine smallpox vaccination by the 1980s following its eradication [3]. In the 2000s, only adults older than 20–25 years would have had a history of smallpox vaccination, leaving the age groups below 20 years vulnerable. Interestingly, the median age of monkeypox cases increased from 10 to 21 years in the next decade. Indeed, most cases were either likely too young to have been vaccinated or were born after the cessation of routine smallpox vaccination, as in the more recent outbreaks.
Anonymous wrote:Anonymous wrote:Isn't the mortality rate believed to be around 1%? That's pretty high!
The most recent study saw a mortality for this clade of a little over 3%. However, it is higher in children and immunocompromised persons.
Anonymous wrote:Anonymous wrote:Anonymous wrote:Isn't the mortality rate believed to be around 1%? That's pretty high!
The most recent study saw a mortality for this clade of a little over 3%. However, it is higher in children and immunocompromised persons.
Citation?
Anonymous wrote:Anonymous wrote:Isn't the mortality rate believed to be around 1%? That's pretty high!
The most recent study saw a mortality for this clade of a little over 3%. However, it is higher in children and immunocompromised persons.
Anonymous wrote:Isn't the mortality rate believed to be around 1%? That's pretty high!
Anonymous wrote:Anonymous wrote:Isn't the mortality rate believed to be around 1%? That's pretty high!
Yes. Cases are going up and no one thought to mention you can die from this virus until now.
Anonymous wrote:Isn't the mortality rate believed to be around 1%? That's pretty high!